. 2020 Jan 24;11:8. doi: 10.4103/ijpvm.IJPVM_541_17

Table 2.

Serum levels of biochemical parameters in the treatment groups at 10 day intervals

Biochemical factors	Group	Baseline	10^th day of intervention	Percent change^# in 10 days	20^th day of intervention	Percent change^# in 20 days	30^th day of intervention	Percent change^# in 30 days	P_time^‡	P_group^‡	P_time*group^‡
FBS (mg/dl)	C	340.7±37.76	367.6±41.64	7.98±4.91	400.6±49.13	16.81±6.27	417.1±46.27	23.76±7.62	<0.0001	<0.05	0.01
	SM	273.9±32.85	236.9±25.35^a	-10.90±4.44^a	190.2±22.1^a*	-24.32±8.61^a	198.9±19.62^a*	-20.69±7.81^a
	PSM	400±71.61	299.16±51.59	-23.06±6.76^a	224.66±41.14^a*	-32.27±10.30^a	184.66±35.05^a*	-48.16±9.53^ab
	SMC	368±58.31	301.55±42.44	-14.64±7.00^a	272.33±38.12^a	-21.11±8.07^a	239±34.2^a*	-29.38±9.21^a
	PSMC	378±37.94	306.37±33.61	-18.87±2.45^a	270.12±37.35^a*	-29.57±3.36^a	184.12±14.97^a*^†	-49.93±2.81^ab
TG (mg/dl)	C	109.44±12.46	125.89±14.86	14.03±4.50	134.55±15.81	22.30±5.13	142.78±16.14	27.83±5.59	<0.05	>0.05	0.008
	SM	127.55±18.97	106.44±17.06	-18.04±4.31^a	93.22±13.62^a	-23.95±6.34^a	97.55±9.31^a	-6.73±11.87
	PSM	139.33±23.38	130.33±27.89	4.43±22.89	120±24.16	4.71±32.06	79.66±5.69^a	-18.54±32.8
	SMC	107.78±12.82	108.44±9	8.63±11.03	99.22±5.46	3.71±13.34	91.89±12.88^a	-12.67±23.74
	PSMC	119.87±15.25	85.75±7.49	-26.14±4.05^ac	77.87±8.98^a	-32.06±7.14^a	62.5±10.29^ab*	-43.44±9.89^a
TC (mg/dl)	C	70.14±3.76	73.79±6.83	4.27±6.12	72.57±9.54	6.06±16.67	75.14±7.51	7.53±10.1	<0.05	>0.05	0.636
	SM	66.4±5.13	68±2.27	7.83±8.83	59.3±3.07	-4.46±10.49	61.2±3.13^a	-0.32±13.22
	PSM	71±7.97	69.66±6.71	-0.84±2.54	61.33±4.32	-11.30±4.45	59.16±6.38^a	-15.84±3.52
	SMC	74.44±4.2	71.88±4.02	-0.89±7.89	63.88±2.85*	-12.19±5.99	60.77±2.14^a*^†	-15.89±6.01
	PSMC	78.37±4.85	71.87±5.04	-7.45±5.46	63.75±3.73*	-17.99±3.6	58.12±2.98^a*^†	-24.64±4.36^a
LDL-C (mg/dl)	C	14.29±3.11	14.62±2.84	11.48±7.66	15.3±3.08	19.54±11.25	16.68±3.09	28.98±9.32	<0.05	>0.05	0.006
	SM	9.33±1.65	10.16±0.98	31.28±17.99	7.1±0.63^a	4.14±25.59	7.2±0.63^a	3.18±25.87
	PSM	15.33±3.96	13.56±3.82	-8.65±12.14^b	10.01±4.48	-35.60±17.28^a	10.67±4.48^a	-35.81±9.7^a
	SMC	8.81±1.07	6.74±1.44^a	-27.16±6.93^ab	6.58±0.89^a	-24.04±6.85	6.12±0.89^a	-26.98±10.88^a
	PSMC	13.77±2.76	8.89±1.76	-30.71±9.23^ab	7.96±1.61^a*	-28.99±11.97^b	8.31±1.61^a*	-31.26±12.36^a
HDL-C (mg/dl)	C	31.83±2.44	31.87±1.84	1.02±2.95	30.86±2.15	-2.68±2.24	31.68±1.05	-5.97±5.78	<0.0001	>0.05	0.02
	SM	30.71±3.33	34.23±2.13	16.18±8.69	32.14±1.89	9.03±7.76	33.33±2.5	12.59±8.59
	PSM	32.66±2.44	38.38±1.87^ac	20.71±11.05	39.48±2.14^abd*	22.50±6.31	41.71±2.45^ab*	28.9±5.61^a
	SMC	32±1.75	33.2±1.47	4.68±3.97	35.34±1.54	11.31±3.51	36.99±1.09*	17.51±5.07
	PSMC	28.91±2.58	35.29±1.65*	30.24±15.17^a	33.77±1.81	25.37±15.88^a	38.26±1.94*	40.08±14.39^ab

C=Control; SM=Soy milk; PSM=Probiotic soy milk; SMC=Soy milk containing essential oil of C. cyminum; PSMC=Probiotic soy milk containing essential oil of C. cyminum. Values are presented as Mean±SEM. ^#Percent change is calculated relative to baseline. One-way ANOVA: ^aP<0.05 vs. control in the same columns; ^bP<0.05 vs. SM in the same columns; ^cP<0.05 vs. SMC group in the same columns; ^dP<0.05 vs. PSMC group in the same columns. Repeated measures ANOVA: *P<0.05 vs. baseline in the same row; ^†P<0.05 vs. after 10 days of intervention in the same row; ^‡P_time, and P_group: Fixed factor; ^‡P_time*group: Interaction effect